Comparison of Antidepressants in the Real-World: Retrospective Cohort Study Using Big Data
Latest Information Update: 11 Dec 2024
At a glance
- Drugs Bupropion (Primary) ; Desvenlafaxine (Primary) ; Duloxetine (Primary) ; Escitalopram (Primary) ; Fluoxetine (Primary) ; Mirtazapine (Primary) ; Paroxetine (Primary) ; Sertraline (Primary) ; Tianeptine (Primary) ; Venlafaxine (Primary) ; Vortioxetine (Primary)
- Indications Depression
- Focus Adverse reactions; Therapeutic Use
- Sponsors Pfizer
Most Recent Events
- 14 Nov 2022 Status changed from active, no longer recruiting to completed.
- 17 Aug 2022 Planned End Date changed from 3 Oct 2022 to 31 Dec 2022.
- 02 Aug 2022 Planned End Date changed from 31 Dec 2022 to 3 Oct 2022.